Health care industry
Gilead’s twice-yearly shot cut HIV infections by 96% in trial
A pharmacist holds a vial of lenacapavir, the new HIV prevention injectable drug. Nardus Engelbrecht | AP Gilead‘s twice-yearly shot reduced HIV infections by 96% in a second large study, the company said Thursday. The positive phase three trial data on Lenacapavir sets the stage for likely approval by the U.S. Food and Drug Administration […]
Read More
Apple turning AirPods into hearing aids underscores effort to crack massive health market
Soon, people with AirPods in their ears might not be drowning you out — they might be wearing them to hear you better. Apple announced on Monday that its AirPods Pro 2 headphones will become an FDA-cleared hearing aid in the coming weeks through a software update. That means that adults with mild or moderate […]
Read More
Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
Digital health company Noom on Thursday announced it will offer a compounded GLP-1 drug as part of a new weight loss product that starts at $149. The treatment will feature compounded semaglutide, the same active ingredient in Novo Nordisk’s blockbuster obesity and diabetes drugs Wegovy and Ozempic. Noom has offered weight loss programs for years, […]
Read More
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. Plexi Images | GHI | UCG | Universal Images Group | Getty Images Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a path forward after the rapid decline of its Covid business. […]
Read More
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer’s drugs
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Thursday said it will invest $1.8 billion to boost manufacturing for its newly approved Alzheimer’s drug and highly popular weight loss and diabetes treatments, among other medicines, […]
Read More
‘Economy class syndrome’ is a medical issue that can happen on flights — no matter where you sit
Experts call it “economy class syndrome” — but it can happen to anyone in any class of an airplane. Deep vein thrombosis, or DVT as it’s known, occurs when blood clots in one or more veins. It can happen at any time, but people who travel on long-haul flights are at a higher risk because […]
Read More
This government-backed startup is growing blood to help fight shortages
Safi employees at work. Courtesy of Safi Biotherapeutics Last month, the American Red Cross declared an emergency blood shortage after its national supply fell by more than 25% in July. One startup’s solution: Lab-grown blood. Shortages can be dire for patients since doctors have to make tough decisions about who needs blood transfusions the most. […]
Read More
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future […]
Read More
AstraZeneca shares fall 5% on disappointing lung cancer drug trial results
AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results. The Covid-19 vaccine maker was trading at the bottom of the FTSE 100 and dragged the wider healthcare sector lower after data published Monday showed that its experimental […]
Read More
Eli Lilly names insider Lucas Montarce as new finance chief
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured in Branchburg, New Jersey, on March 5, 2021. Mike Segar | Reuters U.S. drugmaker Eli Lilly on Monday said it appointed insider Lucas Montarce as its new chief financial officer, effective immediately. Montarce, who joined Lilly in 2001, has held various finance leadership roles within […]
Read More